Zealand, Boehringer receive FDA breakthrough status for treatment of fatty liver dystrophy

Danish Zealand Pharma and German partner Boehringer Ingelheim have won the US Food and Drug Administration’s Breakthrough Therapy competition to review their experimental weight-loss drug for the treatment of fatty liver disease.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM